In spite of the fairly positive corporate update that popped up on the last day of February, the stock of SinoFresh HealthCare, Inc. (PINK:SFSH) has been delivering quite mediocre performance on the stock market. Until yesterday’s announcement by CEO David R. Olund, which gave the trading of SFSH stock a boost. As a result, the latter gained the modest 8% in value, closing at $0.0027 per share on a volume of some 12.9 million.A quick retrospection shows that last month’s highly intensified trading with SFSH shares had much more to do with promotions than with company news. In an attempt to rerun the same movie again, a new advertising campaign was launched yesterday. Though only evaluated at $250, additional promoters might jump on the bandwagon and eventually gather momentum.
Whether new promotions will take place or not is still unclear. At present, Olund is said to be carrying out negotiations with European distributors. Yesterday, he announced that he was extending his stay in Europe in order to bring talks to a successful end.
SinoFresh HealthCare, Inc. occupies the pharmaceutical industry. It pretends to be specialized in developing contemporary therapies designed to treat both respiratory and inflammatory diseases. So far, the company has released a final product on the U.S market. [BANNER]
Unfortunately, the quarterly report covering the period ended Sep. 30, 2010 paints a rather bleak picture with regard to the financial health of the company. It indicates:
The numbers mentioned above leave investors with a sneaking suspicion that SFSH will have trouble finding adequate financing in order to expand both domestically and internationally. That is why even if the current talks in Europe end up in favour of SFSH, Mr. Olund will still have a lot of investor questions to answer.
